Target intelligence / Profile preview

Pathogenic bacteria in the oropharyngeal microbiota

Molecular classification
Other
01

Overview

The oropharyngeal microbiota is a complex community of microorganisms inhabiting the throat and mouth. While many are commensal, certain pathogenic bacteria in the oropharyngeal microbiota—such as Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus—can cause significant disease when they overgrow or invade sterile sites (StatPearls, 2023). These pathogens are responsible for a wide range of infections, including pharyngitis, pneumonia, and otitis media (NCBI, 2022). Therapeutic intervention typically involves the use of broad-spectrum or targeted antibiotics that disrupt essential bacterial processes like cell wall synthesis or protein translation (PubMed, 2021). However, targeting these bacteria poses challenges, including the development of antimicrobial resistance and the unintended destruction of beneficial commensal species, which can lead to dysbiosis (Nature Reviews Microbiology, 2021). Effective management requires balancing the elimination of pathogens with the preservation of the host's natural microbial defense systems. The transition from commensalism to pathogenicity is often mediated by environmental stressors or viral infections that alter the local microenvironment (Frontiers in Cellular and Infection Microbiology, 2020). Understanding the specific molecular interactions between these pathogens and the host is crucial for developing more precise antimicrobial therapies.

Other names
Oropharyngeal pathogensPharyngeal bacterial floraUpper respiratory tract pathogensOropharyngeal flora
02

Mechanism of action

Inhibition of bacterial cell wall synthesis, protein synthesis, and DNA replication

03

Biological functions

Other
04

Disease associations

InfectionOther
05

Safety considerations

Antimicrobial resistanceMicrobiome dysbiosisHypersensitivity reactionsSecondary infections
06

Interacting drugs

Amoxicillin

6 more in the full profile.

07

Biomarkers

Bacterial culture16S rRNA sequencingProcalcitoninC-reactive proteinPathogen-specific PCR

Beyond the preview

Go deeper on Pathogenic bacteria in the oropharyngeal microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacteria in the oropharyngeal microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call